Begin main content

Reports

We found 6732 result(s)

Surveillance mammography after treatment for primary breast cancer

Last Updated: January 1, 2000
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: McGahan L, Noorani HZ. Surveillance mammography after treatment for primary breast cancer. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2000. Considerable controversy exists regarding the frequency and intensity of surveillance following treatment for breast cancer. This paper is a systematic, structu...

Drug treatments for Alzheimer’s disease. II. A review of outcome measures in clinical trials

Last Updated: January 1, 2000
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Wolfson C, Moride Y, Perrault A, Momoli F, Demers L, Oremus M. Drug Treatments for Alzheimer’s Disease. Part 2: A Review of Outcome Measures in Clinical Trials. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2000. Alzheimer’s disease is a devastating disorder of the elderly, which is expected to become ...

Use of Cisapride in patients with non-ulcer dyspepsia: a meta-analysis of randomized trials

Last Updated: January 1, 2000
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Shukla VK, Otten N, Dubé C, Moher D. Use of cisapride in patients with non-ulcer dyspepsia: a meta-analysis of randomized trials. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2000. Objectives To determine the relative effectiveness of cisapride in the treatment of non-ulcer dyspepsia in comparison to...

Criteria for selection of adult recipients for heart, cadaveric kidney, and liver transplantation

Last Updated: July 1, 1999
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Noorani H, McGahan L. Criteria for selection of adult recipients for heart, cadaveric kidney, and liver transplantation. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1999. The demand for solid organs for transplantation continues to exceed, by far, the supply available in Canada. As a result of the se...

Economic analysis of Erythropoietin Use in Surgery

Last Updated: March 9, 1999
Result type: Reports

Cite as: Otten N. Economic evaluation of erythropoietin use in surgery. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1998. The Issue The use of allogeneic (donor) blood transfusion is associated with risks such as the transmission of infectious diseases including HIV and Hepatitis B and C. The perioperativ...

Cox-2 Inhibitors: A Role in Alzheimer’s Disease?

Last Updated: January 1, 1999
Result type: Reports

Celecoxib (Celebrex®) and rofecoxib (Vioxx®) are the first of a new class of nonsteroidal antiinflammatory drugs (NSAIDS) called COX-2 inhibitors. As anti-inflammatory agents they are approved for such disorders as osteoarthritis. The long term adverse effects of older NSAIDs have been one of the primary reasons for the emergence and testing ...

Cilostazol: a replacement for pentoxifylline?

Last Updated: January 1, 1999
Result type: Reports

Cilostazol, a phosphodiesterase III (PDEIII) inhibitor, is a new option for the treatment of intermittent claudication (IC). IC, the most common debilitating symptom of peripheral arterial disease (PAD), is defined as a pain, ache, cramp, numbness, or a sense of muscle fatigue in the legs. It is exacerbated by exercise such as walking and is ...

Predictive genetic testing for breast and prostate cancer

Last Updated: January 1, 1999
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Noorani HZ, McGahan L. Predictive genetic testing for breast and prostate cancer. Ottawa, Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1999. This qualitative review describes the current molecular basis of breast and prostate cancer, assesses the clinical relevance of genetic susceptibility, addresses non-dir...